The landscape of dementia analysis has advanced radically with the appearance of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent assessments that may detect Alzheimer's pathology many years before indications arise. Although these technological developments represent extraordinary progress in comprehending neurodegenerative diseases, they have got... https://peterl319fpy8.wikimidpoint.com/user